EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Volume‐Stable Collagen Matrix as a Recombinant Human Bone Morphogenetic Protein‐2 Carrier for Maxillary Sinus Augmentation: An Experimental In Vivo Study

Chae-Eun Kim, Seung-Hyun Park iD, Kyeong-Won Paeng, Lorenzo Tavelli iD, David T Wu iD, Daniel S Thoma iD, Ronald E Jung, Ui-Won Jung iD, Jae-Kook Cha iD

Journal of Clinical Periodontology · 2026-02 · 53 (2) · 299-307

DOI: 10.1111/jcpe.70054 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Periodontology, online erschienen am 18.10.2025. Verfasst von Chae-Eun Kim und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Periodontology, Research Institute for Periodontal Regeneration, Yonsei University College of Dentistry, Seoul, South Korea. Hauptthemen laut MEDLINE: Bone Morphogenetic Protein 2, Collagen, Sinus Floor Augmentation, Transforming Growth Factor beta. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Korea Health Industry Development Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To test the hypothesis that a volume‐stable collagen matrix ( VCMX ) can serve as an effective rhBMP ‐2 carrier for bone regeneration while compensating for the volume instability of absorbable collagen sponge ( ACS ). Materials and Methods (i) rhBMP ‐2 release kinetics from VCMX and ACS were measured over 7 days by enzyme‐linked immunosorbent assay. (ii) Bilateral sinus augmentations were performed in 15 rabbits using either VCMX or ACS , with or without rhBMP ‐2. After 4 weeks, radiographic and histological analyses were conducted.

Results

The overall release patterns between VCMX and ACS did not differ significantly, although VCMX showed a delayed peak release (at 3 h) compared to ACS (at 10 min). Three‐dimensional radiographic analysis showed greater volumetric gains in VCMX groups than in ACS groups, regardless of rhBMP ‐2 loading. Histologically, VCMX / rhBMP ‐2 group exhibited the largest total augmented area (13.1 ± 2.9 mm 2 ). The use of rhBMP ‐2 led to significant increases in new bone area for both VCMX (3.9 ± 1.1 vs. 1.6 ± 1.3 mm 2 , p = 0.003) and ACS (1.8 ± 0.8 vs. 1.0 ± 0.6 mm 2 , p = 0.035). Notably, the proportion of new bone in the total augmented region was comparable between the VCMX / rhBMP ‐2 and ACS / rhBMP ‐2 groups ( p > 0.05). Conclusion rhBMP ‐2‐loaded VCMX enhances bone regeneration in sinus augmentation, suggesting that its volume maintenance may contribute to the improved clinical and radiographic outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone Morphogenetic Protein 2CollagenSinus Floor AugmentationTransforming Growth Factor betaDrug CarriersAnimalsRabbitsRecombinant ProteinsBone RegenerationHumansMaleAbsorbable Implants

Stichwörter der Autor:innen

animal experimentbone morphogenetic protein‐2sinus floor elevationvolume‐stable collagen matrix

Substanzen

Bone Morphogenetic Protein 2Recombinant ProteinsCollagenrecombinant human bone morphogenetic protein-2Transforming Growth Factor betaDrug Carriers

Autor:innen und Institutionen

  • Department of Periodontology, Research Institute for Periodontal Regeneration, Yonsei University College of Dentistry, Seoul, South Korea.
  • Department of Oral Medicine, Infection, and Immunity, Harvard School of Dental Medicine, Boston, USA.
  • Clinic of Reconstructive Dentistry, Center of Dental Medicine, University of Zurich, Zurich, Switzerland.

ORCID-Profile: Seung-Hyun Park, Lorenzo Tavelli, David T Wu, Daniel S Thoma, Ui-Won Jung, Jae-Kook Cha

Förderung

  • Korea Health Industry Development Institute

Zitieren

APA

Kim, C. E., Park, S. H., Paeng, K. W., Tavelli, L., Wu, D. T., Thoma, D. S., Jung, R. E., Jung, U. W., & Cha, J. K. (2026). Volume‐Stable Collagen Matrix as a Recombinant Human Bone Morphogenetic Protein‐2 Carrier for Maxillary Sinus Augmentation: An Experimental In Vivo Study. Journal of Clinical Periodontology, 53(2), 299-307. https://doi.org/10.1111/jcpe.70054

Vancouver

Kim CE, Park SH, Paeng KW, Tavelli L, Wu DT, Thoma DS, et al. Volume‐Stable Collagen Matrix as a Recombinant Human Bone Morphogenetic Protein‐2 Carrier for Maxillary Sinus Augmentation: An Experimental In Vivo Study. Journal of Clinical Periodontology. 2026;53(2):299-307. doi:10.1111/jcpe.70054

BibTeX
@article{Kim2026,
  author = {Kim, Chae-Eun and Park, Seung-Hyun and Paeng, Kyeong-Won and Tavelli, Lorenzo and Wu, David T and Thoma, Daniel S and Jung, Ronald E and Jung, Ui-Won and Cha, Jae-Kook},
  title = {Volume‐Stable Collagen Matrix as a Recombinant Human Bone Morphogenetic Protein‐2 Carrier for Maxillary Sinus Augmentation: An Experimental In Vivo Study},
  journal = {Journal of Clinical Periodontology},
  year = {2026},
  volume = {53},
  number = {2},
  pages = {299--307},
  doi = {10.1111/jcpe.70054}
}
Kostenlos starten →